ABSTRACT
INTRODUCTION

99
EXPERIMENTAL PROCEDURES 100
Isolation and culture of primary human lung fibroblasts. Human lung fibroblasts were isolated 101 as described previously (44). Briefly, tissue samples from explanted lungs from patients undergoing lung 102 transplantation were obtained and placed in Dulbecco's Modified Eagle Medium (DMEM) with 100 103 U/ml streptomycin, 250 ng/ml amphotericin B, and 100 U/ml penicillin. Alveolated lung tissue was 104 minced, washed in PBS, and plated on 10-cm plates in growth media containing DMEM supplemented 105 with 10% FBS, 2 mM L-glutamine, 100 U/ml streptomycin, 250 ng/ml amphotericin B, and 100 U/ml 106 penicillin. Expanded populations of fibroblasts were subsequently subcultured after 4-5 days, resulting 107 in the development of a homogenous fibroblast population. All primary cultures were used from passage 108 3 to 10.
109
Transfection and Luciferase Assay. Subconfluent cells were co-transfected with desired firefly 110 luciferase reporter plasmid, and thymidine kinase (TK) promoter-driven Renilla luciferase plasmid (TK-111 Rl). Cells were serum-starved, followed by stimulation with desired agonists. Cells were washed and 112 then lysed in protein extraction reagent. Lysates were assayed for firefly and Renilla luciferase activity 113 using the dual luciferase assay kit (Promega). To account for differences in transfection efficiency, 114 firefly luciferase activity of each sample was normalized to Renilla luciferase activity. 115
Knockdown of COX2. For COX2 knockdown, the following siRNA was used: 5'-116 UAGGGCUUCAGCAUAAAGCGU-3', (Qiegen, Valencia, CA). COX siRNA or scrambled RNA were 117 transfected using use Lipofectamine® RNAiMAX transfection reagent (Life Technologies, Grand Island, 118 NY) following manufacture's standard protocol.
119
Cell lysis and Western blotting. After stimulation of cells with desired agonists, cells were lysed 120 in the radioimmunoprecipitation (RIPA) buffer containing 25 mM HEPES (pH 7.5), 150 mM NaCl, 1% 121
Triton X-100, 0.1% SDS, 2 mM EDTA, 2 mM EGTA, 10% glycerol, 1 mM NaF, 200 μM sodium 122 orthovanadate, and protease inhibitor cocktail (Sigma). Cells were scraped, sonicated, a sample taken for 123 the measurement of protein concentration, and the remainder boiled in Laemmli buffer for 5 min. The 124 samples were normalized to the protein content, were subjected to polyacrylamide gel electrophoresis, 125
analyzed by Western blotting with desired primary antibodies and corresponding horseradish peroxidase-126 conjugated secondary antibodies, and developed by an enhanced chemilumeniscence reaction (Pierce).
127
The digital chemilumeniscent pictures were imaged by a Luminescent Image Analyzer LAS-4000 128 (Fujifilm).
129
Reverse transcription-quantitative real-time PCR. RNA STAT-60 (TEL-Test) was used to 130 isolate total RNA following the manufacturer's protocol. RNA was randomly primed and reverse 131 transcribed using the iScript cDNA synthesis kit (Bio-Rad, Hercules, USA) according to the 132 manufacturer's protocols. Real-time PCR analysis was performed using iTaq SYBR Green supermix with 133 ROX (Bio-Rad) in a MyIQ single-color real-time PCR detection system (Bio-Rad), The COX-2 primers 134 were: AGAAAACTGCTCAACACCGGA (forward) and CAAGGGAGTCGGGCAATCAT (reverse).
135
Fluorescent microscopy of stress fibers. For visualization of stress fibers, cells grown on cover 136 slips were fixed in 4% paraformaldehyde in PBS followed by permeabilization with 0.2% Triton X-100 137 in PBS. Cells were then incubated in 2% BSA in PBS, followed by incubation rhodamine-conjugated 138 phalloidin (Life Technologies, Grand Island, NY) for 1 hour at room temperature. Cells were then 139 washed 5 times with PBS and coverslips were mounted using Vectashield mounting medium containing 140 DAPI nuclear stain (Vector Laboratories, Burlingame, CA). Fluorescence images were obtained using an 141
Olympus 1X71 fluorescent microscope.
142
In vitro isolation of stress fibers. Stress fibers were isolated as previously described (45). All the 143 procedures were performed on ice using the buffers containing protease inhibitor cocktail (Sigma). After 144 stimulation with desired agonists, cells were washed with PBS, and then extracted with a buffer 145 containing 2.5mM triethanolamine (pH 8.2) for 30 minutes with 6 buffer changes, followed by extraction 146 with 0.05% NP-40 (pH 7.2) for 5 minutes, and subsequent extraction with 0.5% Triton X-100 (pH 7.2) 147 for additional 5 minutes. Cells were then immediately washed with cold PBS, scraped, and suspended in 148 PBS, followed by centrifugation at 100,000 g for 1 hr. Supernatant was removed, and the pellet was 149 sonicated in 0.5% TX100, 50 mM NaCl, 20 mM Hepes (pH 7.0), 1 mM EDTA. Laemmli buffer was 150 added and samples were boiled for 5 minutes prior to further Western blot analysis as described above. Fig. 10A legend, washed twice at room temperature with 2-ml aliquots of medium 165 containing 150 mM NaCl and 10 mM HEPES-Tris (pH 7.4) and 0.5 ml of medium containing 140 mM 166 NaCl, 5 mM KCl, 1 mM MgCl 2 , 0.1 mM CaCl 2 , 5 mM glucose, 20 mM, HEPES-Tris 20 (pH 7.4), 4 167 mCi/ml 45 Ca ± 1 µM nicardipine or 3 µM KB-R4943 was added to each well. After 5 minutes, isotope 168 uptake was terminated by the addition of 2.5 ml ice-cold medium W. The dishes were transferred onto 169 ice, and the cells were washed 5 times with 2.5 ml of ice-cold medium W. The cells were lysed with 1 ml 170 of 4 mM EDTA/1% sodium dodecyl sulfate, and radioactivity was quantified by liquid scintillation 171 counting. 45 Ca influx was calculated as A/am, where "A" is radioactivity in the cell lysate (cpm), "a" is 172 specific radioactivity of the incubation medium (cpm/pmol), and " m" is the protein content per well 173 (mg). 
RESULTS
186
Ouabain increases COX-2 expression and activates PKA in human lung fibroblasts. As shown 187 in figure 1, quiescent human lung fibroblasts (HLFs) do not express detectable levels of COX-2.
188
Treatment of HLF with 100 nM ouabain resulted in a profound and sustained expression of COX-2 at 189 both mRNA and protein levels (Fig. 1A) . Given the established role of COX-2 in the production of 190 prostanoids that act through receptor-mediated activation of cAMP /PKA signaling, we assessed PKA 191 activation in HLFs by examining phosphorylation of the PKA substrate, vasodilator-stimulated 192 phosphoprotein (VASP), using electrophoretic mobility shift assay as a reporter for PKA activity (9). As 193 shown in figure 1B , 100 nM ouabain stimulated a sustained VASP phosphorylation at 24-48 hours, which 194 paralleled COX-2 expression in HLF cells. Furthermore, the specific inhibitor of COX-2, NS-398 195 completely abolished ouabain-induced VASP shift, while increasing COX-2 expression (Fig 1B) . To 196 confirm the specificity of NS-398, we performed a knockdown of COX-2 mRNA. Figure 1C  197 demonstrates a highly efficient knockdown of COX-2 expression in HLF resulting in suppression of 198 VASP shift triggered by ouabain. Together, these data demonstrate that ouabain induces the expression of 199 COX-2 in HLF, which functionally translates to activation of PKA. Fig. 2A) . These 208 differences were preserved in the presence of nicardipine but were abolished by KB-R4943. Figure 2B  209 shows that KB-R4943 sharply decreases COX-2 expression and VASP shift in response to ouabain.
210
Neither COX-2 expression nor VASP phosphorylation were affected by nicardipinе.
211
Disruption of actin stress fibers by ouabain in HLF. Microscopy analysis showed that ouabain 212 treatment resulted in cell shape transition of human lung fibroblasts (Fig. 3A ) -the effect that was 213 observed at long-term treatment (24-48hours) but not at short-term treatment (up to 6 hours). Because 214 such cell shape changes may associate with cell death, and because ouabain is known to induce apoptosis 215 of various but not all cell types (38, 39), we examined a potential cytotoxic effect of ouabain on HLF by 216 measuring the release of lactate dehydrogenase (LDH). As shown in figure 3B, 100 nM ouabain had no 217 significant cytotoxic effect for up to 48 hours, whereas the positive control H 2 O 2 drove a drastic increase 218 in LDH release. We also did not observe membrane blebbing or accumulation of apoptotic bodies (that 219 commonly accompany apoptosis) in ouabain-treated HLF (Fig. 3A) . On the other hand, a similar shape 220 change in oubain-treated HLF was previously described as "arborisation" or "stellation" in vascular 221 smooth muscle cells treated with agents that disrupt actin filaments or activate PKA (7, 41) . Given that, 222
we examined a potential effect of ouabain on stress fibers in HLF. As shown in figure 3C , ouabain 223 treatment halved the total content of polymerized actin and clearly disrupted the structure of stress fibers, 224
as assessed by phalloidin staining.
225
Ouabain and digoxin inhibit TGF-β1-induced myofibroblast differentiation. We and others 226 have demonstrated that myofibroblast differentiation is highly sensitive to regulation by activators of 227 PKA (21, 44). Given the activation of PKA by ouabain in HLF, we examined its effect on myofibroblast 228 differentiation in response to TGF-β. As shown in figure 4A , treatment of HLF with TGF-β resulted in a 229 profound induction of the expression of myofibroblast differentiation markers, such as smooth muscle-230 specific α-actin (SM-α-actin), fibronectin and collagen-1. Ouabain inhibited the expression of 231 myofibroblast markers in response to TGF-β1, which paralleled to its effect on COX-2 expression. We 232 also examined the effect of clinically relevant cardiac glycoside, digoxin, on myofibroblast 233 differentiation. As shown in figure 4B , digoxin similarly stimulated expression of COX-2, 234 phosphorylation of VASP and completely blocked myofibroblast differentiation in response to TGF-β. 235
Upon stimulation with TGF-β1, fibroblasts respond by altering their ultrastructure by formation 236 of prominent actin stress fibers and modified focal adhesion complexes, which provide mechanical 237 coupling to the surrounding matrix and increased contractility of myofibroblasts (18, 53) . In addition, 238 actin stress fiber formation plays a signaling role in driving the activation of serum response factor (SRF) 239
and SRF-dependent expression of several myofibroblast markers including SM-α-actin (44, 45). 240 Therefore, we examined the effect of ouabain on this pathway. Consistently with previous data (45), a 48 241 hour exposure to TGF-β1 resulted in stress fiber formation, as quantitatively examined by biochemical 242 isolation of stress fibers (Fig. 5A ). Importantly, ouabain decreased TGF-β-induced stress fiber formation. 243
Furthermore, ouabain attenuated TGF-β-induced SRF-luciferase reporter activity (Fig. 5B) . Together, 244 these data suggest that ouabain attenuates TGF-β-induced myofibroblast differentiation through a 245 disruption of actin stress fibers and inhibition of SRF activity. examined the role of COX-2-dependent PKA activation in the inhibitory effect of ouabain on 266 myofibroblast differentiation, first using COX-2 inhibitor NS-398. As shown above, this compound at 267 concentration of 1 µM completely blocked ouabain-induced VASP phosphorylation as an indicator of 268 PKA activity in HLF (Fig. 1B) . However, NS-398 failed to abolish the inhibitory effect of ouabain on 269 myofibroblast differentiation (Fig. 8A) . We and others have demonstrated that Rho / Rho kinase (ROCK) 270 signaling is critical for TGF-β-induced stress fiber formation and SRF-dependent expression of 271 myofibroblast marker proteins. Therefore, we examined the contribution of COX-2 expression on the 272 regulation of this signaling pathway by ouabain, by assessing phosphorylation of cofilin as a downstream 273 target of ROCK and a reporter of it's activity, as we performed previously (45). As shown in figure 8A , 274 ouabain inhibited TGF-β-induced phosphorylation of cofilin; however, NS-398 failed to reverse this 275 effect.
276
Considering the possibility of prostaglandin-independent effects of COX-2, we then used the 277 knockdown approach. As shown in figure 8B , transfection of HLF with COX-2 siRNA resulted in a 278 complete attenuation of ouabain-induced COX-2 expression. However, this did not affect the ability of 279 ouabain to inhibit TGF-β-induced myofibroblast differentiation or cofilin phosphorylation as a reporter of 280
Rho signaling. Finally, we considered the role of [Ca 2+ ] i increase via activation of the reverse mode of the 281 Na + /Ca 2+ exchanger in the action of ouabain (Fig. 2) . As show in figure 8C, ouabain, but may act together with other mechanisms yet to be identified. Given previously established 300 antifibrotic role of COX-2 and PKA (8, 22, 23, 33, 59) , the latter possibility is quite plausible.
301
Our results show for the first time that cardiac glycosides suppress TGF-β-induced fibrotic 302 signaling (Rho activation, stress fiber formation and SRF activation (Figs. 5, 8) ) as well as myofibroblast 303 differentiation of cultured HLFs (expression of collagen-1, fibronectin and smooth muscle-α-actin) ( Fig.  304 4) without any impact on their survival (Fig. 3B ). During the last two decades, a number of studies 305
reported that along with Na+,K+-pump inhibition and modulation of canonical Na (Fig. 7) . These data strongly suggest that cardiac glycosides inhibit myofibroblast differentiation via 314 Na
It is noteworthy that actions of cardiac glycosides on fibrotic response may be cell-specific. It was 316
shown that certain inhibitors of Na+,K+-ATPase increase collagen synthesis by cultured rat cardiac 317 fibroblasts, human dermal fibroblasts, or rat vascular smooth muscle cells (13-16). However, these studies 318 have not rigorously examined the effect of these compounds on the expression of myofibroblast 319 differentiation markers, on the magnitude of their effect relative to that of TGF-β, or on their effect on 320 TGF-β-induced myofibroblast differentiation. Further, the association of the effects of these compounds 321 on collagen synthesis with their actions on the [ 1, 4, 6). Furthermore, ouabain blocked TGF-β-induced Rho activation (Fig. 7) , stress fiber formation and 342 SRF activation (Fig. 5) -the processes critical for myofibroblast differentiation and known to be 343 regulated by PKA (44, 45). We also showed that both COX-2 inhibitor NS-398 and siRNA-induced 344 COX-2 knockdown completely abolished VASP shift seen in ouabain-treated HLF (Fig. 1) glycosides inhibit α1-Na + /K + -ATPase at concentrations of up to 4 orders of magnitude higher than in 367 other mammals, whereas the affinities of rodent α2-and α3-subunits for cardiac glycosides are similar to 368 those in other mammals (46). Given that α1 subunit is a predominant isoform expressed in mouse lung 369 fibroblasts (data not shown), wild type rodents could not be used for assessing the antifibrotic effect of 370 cardiac glycosides models of pulmonary fibrosis. The resistance to cardiac glycosides is caused by a 371 substitution of Gln111 and Asn122 of human α1-subunit for Arg and Asp, respectively, in rodents. Based 372 on this, Lingrel and co-workers have generated a mouse with knock-in of ouabain-sensitive α1 isoform 373 (α1 s/s ) of Na,K-ATPase and have used it to delineate the role of α1 in blood pressure regulation, cardiac 374 and skeletal muscle contraction and renal salt handling (28). These mice can be also used for elucidation 375 of the antifibrotic effect of cardiac glycosides in vivo in the models of pulmonary fibrosis, which is our 376 future goal. (HLF). Serum-starved HLFs were treated with 100 nM ouabain with or without 1 μM NS-398 for the 394 times indicated. Cells were analyzed by real time qPCR for COX-2 mRNA levels (A), or by Western 395 blotting for COX-2 expression and VASP shift (A-C). C, HLFs were transfected with a scramble or 396 COX-2 siRNAs, serum-starve for 24 hours and treated with 10 nM ouabain for 24 hours. Shown are the 397
Western blots for COX-2 and VASP. 398 399 Figure 2 . Effect of ouabain, nicardipine and KB-R7943 on 45 Ca 2+ influx, and on COX-2 expression 400 and VASP shift. A. HLFs were preincubated for 24 hr in the presence of 100 nM ouabain, 1 mM 401 nicardipine or 3 mM KB-R7943, and the rate of 45 Ca 2+ influx was measured as described in Methods. 402
Means ± S.E. from experiments performed in triplicate are shown. B. HLFs were treated with 100 nM 403 ouabain, 1 mM nicardipine or 3 mM KB-R7943 for 24 hours, and cell extracts were examined by Western 404 blotting for COX-2 expression and VASP shift. Cell extracts were either lysed (total) or were processed for isolation of stress fibers, followed by Western 420 blotting with desired antibodies. B, effect of iincreaseing concentrations of ouabain (100 nM, 48 hours) 421 on SRF-luciferase reporter activity. 422 423 Figure 6 . Effect of K + -free medium on intracellular Na + content and on COX-2 expression, VASP 424 phosphorylation and myofibroblast differentiation. HLFs were treated with a control medium ([K + ] o =5 425 mM), K + -free medium, or with 100 nM ouabain in a control medium for 48 hours, with or without 1 426 ng/ml TGF-β for 48 hours as indicated. A, intracellular Na + concentration was measured as described in 427
Methods. B, Cell extracts were analyzed by Western blotting with desired antibodies as indicated. 428 429 Figure 7 . Dose-dependent actions of ouabain on intracellular Na+ and K+ content, COX-2 430 expression, and expression of myofibroblast differentiation markers. A, HLFs were treated with 431 ouabain for 48 hours and assessed for intracellular Na+ and K+ content. Means ± S.E. from experiments 432 performed in trplicate are shown. B, HLFs were treated with 1 ng/ml TGF-β in the presence of increasing 433 doses of ouabain for 48 hours. Cell extracts were examined by Western blotting for COX-2 expression, 434 and myofibroblast differentiation markers. Shown are the representative images from three independent 435 experiments. C, Densitometry of ECL for Collagen-1, SM-α-actin and fibronectin Western blots (mean ± 436 SD from three independent experiments). * p<0.05; ** p<0.01) 437 438 or pre-transfected with a control or COX-2 siRNA (B), or treated with 3 µM KB-R7943 (C), 441 followed by incubation with 100 nM ouabain, or 1 ng/ml TGF-β for 48 hours as indicated. HLFs were preincubated for 24 hr in the presence of 100 nM ouabain, 1 mM nicardipine or 3 mM KB-R7943, and the rate of 45 Ca 2+ influx was measured as described in Methods. Means ± S.E. from experiments performed in triplicate are shown. B. HLFs were treated with 100 nM ouabain, 1 mM nicardipine or 3 mM KB-R7943 for 24 hours, and cell extracts were examined by Western blotting for COX-2 expression and VASP shift. 
